New Psoriasis Treatment Ilumya FDA-approved

 Sun Pharmaceutical's Ilumya was approved by the U.S. Food and Drug Administration to treat adults with moderate to severe cases of the skin condition plaque psoriasis, who are also candidates for systemic therapy or phototherapy.

We have BLU-U PhotoDynamic Light Therapy in the Norfolk, VA branch.

Request an Appointment with Amanda Hullett, PA-C's Support Team

“With the approval of Ilumya and our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque psoriasis,” Abhay Gandhi, president and CEO of the North American division of Sun Pharma, said in a press release. 

Comments: